Blog Archives

Blog

Application of PK/PD Modeling and Simulation in Drug Discovery and Development in China

By Yuancheng Chen, Research Associate of Phase 1 Unit, Huashan Hospital, Fudan University, and visiting…

Certara2020年8月7日

Blog

The Research to Accelerate Cures and Equity (RACE) for Children Act: Changing the Landscape of Pediatric Cancer Drug Development

3 key tips to set your pediatric program up for success with the RACE for…

Certara2020年7月14日

Blog

Local Therapies for the Global COVID-19 Pandemic

Henri Merdjan explains why topical drug formulations (e.g. intranasal and/or oral) could be valuable as…

Certara2020年5月29日

Blog

Applying decision analysis to drug development for COVID-19 & future pandemics

This blog discusses how decision analysis approaches can help drug developers to better decisions under…

Certara2020年4月30日

Blog

Getting started with in-house development: 絵コンテ

Introducing our three-part blog series on getting started with in-house development. In this series, we’re…

Certara2020年2月21日

ブログ

Getting started with in-house development: how does it work?

Introducing our three-part blog series on getting started with in-house development. In this series, we’re…

Certara2020年2月10日

Blog

Using Model-based Meta-analysis to Inform Neuropathic Pain Drug Development

Model-based Meta-analysis is a framework to compare drugs used to treat diabetic peripheral neuropathy, post-herpetic…

Certara2019年12月19日

Blog

Patient Engagement and Patient Centricity Series Part II: Types of Patient Advocates

Nirpal Virdee, Synchrogenix’s Global Head of Transparency and Disclosure recently sat down with Trishna Bharadia,…

Certara2019年11月11日

Blog

ICER’s Unsupported Drug Price Increase Report: An Analysis

We analyze the drug-price watchdog, ICER’s (Institute for Clinical and Economic Review) “Report on Unsupported…

Certara2019年10月24日

Blog

Health Canada PRCI Guiding Principles and Observations

Health Canada released guidance on 2019年3月12日 pertaining to its Public Release of Clinical…

Certara2019年9月16日

Powered by Translations.com GlobalLink Web Software

ブログ

Application of PK/PD Modeling and Simulation in Drug Discovery and Development in China

The Research to Accelerate Cures and Equity (RACE) for Children Act: Changing the Landscape of Pediatric Cancer Drug Development

Local Therapies for the Global COVID-19 Pandemic

Applying decision analysis to drug development for COVID-19 & future pandemics

Getting started with in-house development: 絵コンテ

Getting started with in-house development: how does it work?

Using Model-based Meta-analysis to Inform Neuropathic Pain Drug Development

Patient Engagement and Patient Centricity Series Part II: Types of Patient Advocates

ICER’s Unsupported Drug Price Increase Report: An Analysis

Health Canada PRCI Guiding Principles and Observations

メルマガ登録

クイックアクセス

ソリューション

お問合せ